Answer
Deucravacitinib is contraindicated in hypersensitivity to the active substance or any excipient and in clinically important active infections, such as active tuberculosis.
Sources for this answer
- SOTYKTU 6 mg film coated tabletsBristol Myers Squibb Pharmaceuticals limited · emc · SmPC §4.3 Contraindications · Version 3Document updated
Sources checked